Local research. Human connections. WCR Miami Lakes (786) 483-7856
Back to study searchNCT05712577
RecruitingNCT05712577ClinicalTrials.gov record

Psychological Support in Adult Patients With Marfan Syndrome

Rare Diseases · Marfan Syndrome · Psychology, Social

THE QUICK READ

What this study involves

The registry says this study is recruiting. Individual locations may have different availability.

Study type
Observational
Phase
Not applicable / not listed
Age range
18 years - Not specified
Sex eligible
All sexes
Healthy volunteers
Not accepted
Participants
125 Estimated

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

The goal of this observational study is to identify key factors leading to psychotherapy or psychological support in adult subjects with Marfan syndrome (MSF). the main questions it aims to answer are:

  • Understand and define which internal variables of the individual drive this request for psychological support;
  • To learn about verify the impact that the clinical manifestations of MSF have on psychosocial aspects, self-esteem, subjective perception of the disease and coping mechanisms.
Read the full description

Patients following psychological interview during follow-up visits will be enrolled in the study.

The following self-report questionnaires will be used in understanding the impact the syndrome has on mental health and quality of life:

  • Rosenberg Self- Esteem: 10 item Likert scale for assessing self-esteem;
  • SF 36: 36 item scale assessing eight domains: physical functioning physical role limitations; bodily pain; general health perceptions; energy/vitality; social functioning; emotional role limitations and mental health;
  • Cope NVI: to test measures coping behaviors as potential responses to stressors like social support, avoidance strategies, positive attitude, problem orientation and transcendent orientation;
  • OQ45.2: measure of general psychological distress.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

  • Subjects affected by Marfan syndrome;
  • Subjects currently in follow-up at Cardiovascular Genetic Centre, IRCCS Policlinico San Donato;
  • Signed informed consent.

Exclusion Criteria:

  • Subjects with cognitive deficits

Study population

Subjects with MFS who have requested psychological support/psychotherapy and patients who have never requested psychological support/psychotherapy.

Understand screening

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment
Not reported
Masking
Not reported
MFS_PT+

MFS patients who followed psychological support/psychotherapy

Other: Questionnaire

MFS_PT-

MFS patients who never followed psychological support/psychotherapy

Other: Questionnaire

Questionnaire OTHER

Rosenberg Self- Esteem scale

Questionnaire OTHER

Short Form 36 scale

Questionnaire OTHER

Coping orientation to the problems experienced - New Version in Italian

Questionnaire OTHER

Outcome Questionnaire - version 42.5

Prepare your questions

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Questionnaire performance

Time frame: 8 Months

Statistical analysis between the two experimental groups using independent samples t-tests for continuous variables and associations for categorical variables.

Questionnaire scoring:

\- COPE NVI: scoring between 60 and 240; higher score means better outcome

Questionnaire performance

Time frame: 8 Months

Statistical analysis between the two experimental groups using independent samples t-tests for continuous variables and associations for categorical variables.

Questionnaire scoring:

\- Short Form-36: scoring between 0 and 100; higher score means better outcome

Questionnaire performance

Time frame: 8 Months

Statistical analysis between the two experimental groups using independent samples t-tests for continuous variables and associations for categorical variables.

Questionnaire scoring:

\- Rosenberg Self- Esteem scale: scoring between 0 and 30; higher score means better outcome

Questionnaire performance

Time frame: 8 Months

Statistical analysis between the two experimental groups using independent samples t-tests for continuous variables and associations for categorical variables.

Questionnaire scoring:

\- Outcome questionnaire 42.5: socring between 0 and 180; clinical cut-off value is 64, higher score means worse outcome

No results are flagged as posted.

Review the complete result tables and limitations in the official record.

Open official results ↗

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

IRCCS Policlinico San DonatoSan Donato Milanese, Lombardy, ItalyRecruiting

Study team and timeline

Lead sponsor
IRCCS Policlinico S. Donato
Study start
Jan 9, 2023 Actual
Primary completion
Feb 9, 2027 Estimated
Study completion
Oct 9, 2027 Estimated
First posted
Feb 3, 2023 Actual
Last updated
Nov 10, 2026 Actual

Official study contacts

Official study title

Psychological Help in Patients With Marfan Syndrome: the Role of Quality of Life, Coping Mechanisms, Psychosocial Aspects and Self-esteem Levels

A HUMAN NEXT STEP

Ask Wellness Clinical Research

Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.

Please do not include medical records, diagnoses, medications, insurance numbers or other sensitive details. This form is for general questions, not urgent care.

Sending a question does not enroll you in a trial.

Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.

Retrieved: Nov 12, 2026 · Last registry update: Nov 10, 2026